date:May 11, 2012
mpanies, he said.
Dr Fabricant told attendees at the AHPA Botanical Congress that the most common areas of cGMP noncompliance discovered during FDA investigations, include:
Failure to prepare a master manufacturing record
Failure to prepare a batch record
Failure to establish specifications
Failure to determine if specifications are met
Failure of adequate quality control